NCT00774644View on ClinicalTrials.gov

Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

January 31, 2003

Study Completion Date

February 28, 2003

Conditions
Healthy
Interventions
DRUG

Clarithromycin 500mg

Trial Locations (1)

63301

Gateway Medical Research Inc., Saint Charles

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00774644 - Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions. | Biotech Hunter | Biotech Hunter